Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Preferred Stock Liabilities (2017 - 2025)

Jaguar Health (JAGX) has disclosed Preferred Stock Liabilities for 7 consecutive years, with $2.5 million as the latest value for Q1 2025.

  • On a quarterly basis, Preferred Stock Liabilities changed 0.0% to $2.5 million in Q1 2025 year-over-year; TTM through Mar 2025 was $2.5 million, a 0.0% change, with the full-year FY2024 number at $2.5 million, changed N/A from a year prior.
  • Preferred Stock Liabilities was $2.5 million for Q1 2025 at Jaguar Health, roughly flat from $2.5 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $2.5 million in Q1 2024 to a low of $2.5 million in Q1 2024.